The foundation of our work began in 1998 when European scientists Dr. Jindřich Kára and Dr. Alois Novacek made a remarkable discovery. Dr. Kára, a distinguished biochemist at the Czechoslovak Institute of Molecular Genetics, identified unique bioactive phospholipid compounds with potential for cellular regeneration. Dr. Novacek, a renowned scientist with over 100 patents, developed an innovative production technology that dramatically enhanced the effectiveness of these compounds.
This breakthrough led to a partnership with Prague-based Areko, resulting in Ovosan — a pioneering nutritional formulation that launched across Europe. Building on this foundation, Immod Innovations was established in the United States to advance this research and bring the next generation of cellular health support to a broader audience.
Our defining moment came through research at the University of Colorado Anschutz Medical Campus, where scientists discovered that our Bio-Active Phospholipids activate Natural Killer (NK) cells — the body's first line of immune defense. This validation transformed our understanding of how targeted phospholipids can support the immune system at the cellular level, leading to the development of CellBB.
With decades of combined experience in phospholipid research, pharmaceutical development, and international sales, our leadership team has the expertise to drive innovation in dietary supplements and pharmaceuticals.
"The NK cells are internal part of the innate immunity.. It's the first line defense. They are guardians that help you to vent off all infections that come at you."
The scientific team behind CellBB’s research includes renowned researchers with extensive experience in cellular biology, biochemistry, and pharmaceutical science. Their collective expertise has been instrumental in the validation of a product that stands at the forefront of cellular rejuvenation technology.
Meet the Team of Experts of Machavert behind CellBB:
Chris Johnson , Dr. Jakub Staszak Dr. Neal Goodwin, Dr. Greg Miknis, Dr. Jason Duex and Dr. Mani Kandasamy,
The scientific prowess of Machavert Pharmaceuticals and the innovative spirit of our research team have transformed cutting-edge phospholipid science into a discovery of the activation of NK cells by a phospholipid from CellBB to unlock your body’s natural potential for renewal and vitality.
At the core of our products is BAP™ (Bio-Active Phospholipids), a proprietary complex developed through decades of research. Clinical studies at the University of Colorado demonstrated BAP™'s ability to activate Natural Killer cells, supporting your body's natural immune response.
Our formulations combine this cutting-edge lipid technology with rigorous quality standards to deliver consistent, research-backed cellular health support.
